Skip to main content

Laboratory Features and Pathology of the Cytokine Storm Syndromes

  • Chapter
  • First Online:

Abstract

This chapter describes the proposed pathogenesis of the cytokine storm syndromes (hemophagocytic lymphohistiocytosis and macrophage activation syndrome), the laboratory findings associated with these diseases, and the currently recommended diagnostic strategies. The pathogenesis of primary forms of hemophagocytic lymphohistiocytosis (HLH) is based on an impaired function of cytotoxic T-lymphocytes and NK cells, which then leads to an inability of the immune system to clear the original antigenic insult, ultimately resulting in an uncontrolled release of cytokines. The exact pathogenesis of secondary HLH and macrophage activation syndrome, while presumably similar, is not well understood. Laboratory findings are nonspecific and comprise cytopenias, altered liver function tests, hypofibrinogenemia, hypertriglyceridemia, hyperferritinemia, altered cerebrospinal fluid analysis in patient with neurologic symptoms, and tissue hemophagocytosis. Diagnostic strategies include an initial testing assessment to detect the above-described changes that support the clinical concern for HLH. Disease-specific testing, available only in few laboratories, includes levels of soluble CD25, NK cell function assay, flow cytometric techniques for screening, and genetic testing for the mutations associated with primary HLH.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Janka, G. (2009). Hemophagocytic lymphohistiocytosis: When the immune system runs amok. Klinische Pädiatrie, 221, 278–285.

    Article  CAS  PubMed  Google Scholar 

  2. Grom, A. A. (2004). Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis and Rheumatism, 50, 689–698.

    Article  PubMed  Google Scholar 

  3. Rosado, F. G. N., & Kim, A. S. (2013). Hemophagocytic lymphohistiocytosis: An update on diagnosis and pathogenesis. American Journal of Clinical Pathology, 139, 713–727.

    Article  CAS  PubMed  Google Scholar 

  4. Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015). Perforin and granzymes: Function, dysfunction and human pathology. Nature Reviews Immunology, 15, 388–400.

    Article  CAS  PubMed  Google Scholar 

  5. Goransdotter, E. K., Fadeel, B., Nilsson-Ardnor, S., Söderhäll, C., Samuelsson, A., Janka, G., et al. (2001). Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. American Journal of Human Genetics, 68, 590–597.

    Article  Google Scholar 

  6. Stepp, S. E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P. A., et al. (1999). Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286, 1957–1959.

    Article  CAS  PubMed  Google Scholar 

  7. Ménasché, G., Feldmann, J., Fischer, A., & de Saint Basile, G. (2005). Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunological Reviews, 203, 165–179.

    Article  PubMed  Google Scholar 

  8. Lichtenheld, M. G., Olsen, K. J., Lu, P., Lowrey, D. M., Hameed, A., Hengartner, H., et al. (1988). Structure and function of human perforin. Nature, 335, 448–451.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang, K., Filipovich, A. H., Johnson, J., Marsh, R. A., & Villanueva, J. (2013). Hemophagocytic lymphohistiocytosis, familial. In M. P. Adam, H. H. Ardinger, R. A. Pagon, et al. (Eds.), GeneReviews® (pp. 1993–2017). Seattle, WA: University of Washington, Seattle.

    Google Scholar 

  10. Ohadi, M., Lalloz, M. R., Sham, P., Zhao, J., Dearlove, A. M., Shiach, C., et al. (1999). Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. American Journal of Human Genetics, 64, 165–171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Johnson, T. S., Villanueva, J., Filipovich, A. H., Marsh, R. A., & Bleesing, J. J. (2011). Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. Journal of Immunological Methods, 364, 1–13.

    Article  CAS  PubMed  Google Scholar 

  12. Gholam, C., Grigoriadou, S., Gilmour, K. C., & Gaspar, H. B. (2011). Familial haemophagocytic lymphohistiocytosis: Advances in the genetic basis, diagnosis and management. Clinical and Experimental Immunology, 163, 271–283.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., et al. (2003). Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell, 115, 461–473.

    Article  CAS  PubMed  Google Scholar 

  14. zur Stadt, U., Schmidt, S., Kasper, B., Beutel, K., Diler, A. S., Henter, J. I., et al. (2005). Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Human Molecular Genetics, 14, 827–834.

    Article  CAS  PubMed  Google Scholar 

  15. zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., et al. (2009). Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. American Journal of Human Genetics, 85, 482–492.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Verbsky, J. W., & Grossman, W. J. (2006). Hemophagocytic lymphohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives. Annals of Medicine, 38, 20–31.

    Article  CAS  PubMed  Google Scholar 

  17. Li, F. Y., Chaigne-Delalande, B., Su, H., Uzel, G., Matthews, H., & Lenardo, M. J. (2014 Apr). XMEN disease: A new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood, 123(14), 2148–2152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rosado, F. G., Rinker, E. B., Plummer, W. D., Dupont, W. D., Spradlin, N. M., Reichard, K. K., et al. (2016). The diagnosis of adult-onset haemophagocytic lymphohistiocytosis: Lessons learned from a review of 29 cases of bone marrow haemophagocytosis in two large academic institutions. Journal of Clinical Pathology, 69, 1–5.

    Article  Google Scholar 

  19. Puente, J., Carvajal, T., Parra, S., Miranda, D., Sepulveda, C., Wolf, M. E., et al. (1993). In vitro studies of natural killer cell activity in septic shock patients: Response to a challenge with alpha-interferon and interleukin-2. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 31, 271–275.

    CAS  PubMed  Google Scholar 

  20. von Muller, L., Klemm, A., Durmus, N., Weiss, M., Suger-Wiedeck, H., Schneider, M., et al. (2007). Cellular immunity and active human cytomegalovirus infection in patients with septic shock. The Journal of Infectious Diseases, 196, 1288–1295.

    Article  CAS  Google Scholar 

  21. Smith, M. C., Cohen, D. N., Greig, B., Yenamandra, A., Vnencak-Jones, C., Thompson, M. A., et al. (2014). The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. International Journal of Clinical and Experimental Pathology, 7, 5738–5749.

    PubMed  PubMed Central  Google Scholar 

  22. Henter, J. I., Elinder, G., & Ost, A. (1991). Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Seminars in Oncology, 18, 29–33.

    CAS  PubMed  Google Scholar 

  23. Su, I. J., Chen, R. L., Lin, D. T., & Chen, C. (1994). Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. The American Journal of Pathology, 144, 1219–1225.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Kasahara, Y., Yachie, A., Takei, K., Kanegane, C., Okada, K., Ohta, K., et al. (2001). Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood, 98, 1882–1888.

    Article  CAS  PubMed  Google Scholar 

  25. Lay, J. D., Tsao, C. J., Chen, J. Y., Kadin, M. E., & Su, I. J. (1997). Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. The Journal of Clinical Investigation, 100, 1969–1979.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chuang, H. C., Lay, J. D., Hsieh, W. C., Wang, H. C., Chang, Y., Chuang, S. E., et al. (2005). Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood, 106, 3090–3096.

    Article  CAS  PubMed  Google Scholar 

  27. Kawaguchi, H., Miyashita, T., Herbst, H., Niedobitek, G., Asada, M., Tsuchida, M., et al. (1993). Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. The Journal of Clinical Investigation, 92, 1444–1450.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kasahara, Y., & Yachie, A. (2002). Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Critical Reviews in Oncology/Hematology, 44, 283–294.

    Article  PubMed  Google Scholar 

  29. Chuang, H. C., Lay, J. D., Hsieh, W. C., & Su, I. J. (2007). Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: Nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Science, 98, 1281–1287.

    Article  CAS  PubMed  Google Scholar 

  30. Wang, H., Xiong, L., Tang, W., Zhou, Y., & Li, F. (2017). A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget, 8, 59977–59985.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Deane, S., Selmi, C., Teuber, S. S., & Gershwin, M. E. (2010). Macrophage activation syndrome in autoimmune disease. International Archives of Allergy and Immunology, 153, 109–120.

    Article  CAS  PubMed  Google Scholar 

  32. Janka, G. E. (2012). Familial and acquired hemophagocytic lymphohistiocytosis. Annual Review of Medicine, 63, 233–246.

    Article  CAS  PubMed  Google Scholar 

  33. Henter, J. I., Tondini, C., & Pritchard, J. (2004). Histiocyte disorders. Critical Reviews in Oncology/Hematology, 50, 157–174.

    Article  PubMed  Google Scholar 

  34. Zhang, M., Behrens, E. M., Atkinson, T. P., Shakoory, B., Grom, A. A., & Cron, R. Q. (2014). Genetic defects in cytolysis in macrophage activation syndrome. Current Rheumatology Reports, 16(9), 439.

    Article  PubMed  CAS  Google Scholar 

  35. Kaufman, K. M., Linghu, B., Szustakowski, J. D., Husami, A., Yang, F., Zhang, K., et al. (2014). Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis & Rhematology, 66(12), 3486–3495.

    Article  CAS  Google Scholar 

  36. Vastert, S. J., van Wijk, R., D’Urbano, L. E., de Vooght, K. M., de Jager, W., Ravelli, A., et al. (2010). Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford, England), 49(3), 441–449.

    Article  CAS  Google Scholar 

  37. Janka, G., & zur Stadt, U. (2005). Familial and acquired hemophagocytic lymphohistiocytosis. In ASH Education Book (Vol. 2005 no. 1, pp. 82–88).

    Google Scholar 

  38. Okamoto, M., Yamaguchi, H., Isobe, Y., Yokose, N., Mizuki, T., Tajika, K., et al. (2009). Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Internal Medicine, 48(10), 775.

    Article  PubMed  Google Scholar 

  39. Henter, J. I., & Nennesmo, I. (1997). Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. The Journal of Pediatrics, 130(3), 358.

    Article  CAS  PubMed  Google Scholar 

  40. Gratton, S. M., Powell, T. R., Theeler, B. J., Hawley, J. S., Amjad, F. S., & Tornatore, C. (2015). Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood. Journal of the Neurological Sciences, 357(1–2), 136–142.

    Article  PubMed  Google Scholar 

  41. Recalcati, S., Invernizzi, P., Arosio, P., & Cairo, G. (2008). New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity. Journal of Autoimmunity, 30, 84–89.

    Article  CAS  PubMed  Google Scholar 

  42. Kelly, A., & Ramanan, A. V. (2007). Recognition and management of macrophage activation syndrome in juvenile arthritis. Current Opinion in Rheumatology, 19, 477–481.

    Article  CAS  PubMed  Google Scholar 

  43. Lai, S., Merritt, B. Y., Chen, L., Zhou, X., & Green, L. K. (2012). Hemophagocytic lymphohistiocytosis associated with influenza A (H1N1) infection in a patient with chronic lymphocytic leukemia: An autopsy case report and review of the literature. Annals of Diagnostic Pathology, 16, 477–484.

    Article  PubMed  Google Scholar 

  44. Foucar, K. (2010). Histiocytic disorders in bone marrow. In K. Foucar, K. Reichard, & D. Czuchlewski (Eds.), Bone marrow pathology (3rd ed.). Chicago, IL: American Society for Clinical Pathology.

    Google Scholar 

  45. Hsi, E. D. (2007). Hematopathology: A volume in foundations in diagnostic pathology series. London: Churchill Livingstone.

    Google Scholar 

  46. Aronson, I. K., & Worobec, S. M. (2010). Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: An overview. Dermatologic Therapy, 23, 389–402.

    Article  PubMed  Google Scholar 

  47. Minoia, F., Davì, S., Horne, A., Demirkaya, E., Bovis, F., Li, C., et al. (2014). Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients. Arthritis & Rhematology, 66(11), 3160–3169.

    Article  Google Scholar 

  48. Chen, J. H., Fleming, M. D., Pinkus, G. S., Pinkus, J. L., Nichols, K. E., Mo, J. Q., et al. (2010). Pathology of the liver in familial hemophagocytic lymphohistiocytosis. The American Journal of Surgical Pathology, 34, 852–867.

    Article  PubMed  Google Scholar 

  49. Ost, A., Nilsson-Ardnor, S., & Henter, J. I. (1998). Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology, 32(4), 310.

    Article  CAS  PubMed  Google Scholar 

  50. Rezk, S. A., Sullivan, J., & Woda, B. (2011). Non-neoplastic histiocytic proliferations of lymph nodes and bone marrow. In E. S. Jaffe, N. L. Harris, J. W. Vardiman, E. Campo, & D. A. Arber (Eds.), Hematopathology. Philadelphia, PA: Elsevier Saunders.

    Google Scholar 

  51. Hemophagocytic lymphohistiocytosis/hemophagocytic syndromes. In: RN Miranda, Joseph D. Khoury, L. Jeffrey Medeiros. Atlas of lymph node pathology, Springer Science+Business Media, New York, 2013

    Google Scholar 

  52. Millsop, J. W., Ho, B., Kiuru, M., Fung, M. A., & Sharon, V. R. (2016). Cutaneous hemophagocytosis: Bean bags from the bone. JAMA Dermatology, 152(8), 950–952.

    Article  PubMed  Google Scholar 

  53. Larroche, C., & Mouthon, L. (2004). Pathogenesis of hemophagocytic syndrome (HPS). Autoimmunity Reviews, 3, 69–75.

    Article  CAS  PubMed  Google Scholar 

  54. Schneider, E. M., Lorenz, I., Walther, P., & Janka-Schaub, G. E. (2003). Natural killer deficiency: A minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? Journal of Pediatric Hematology/Oncology, 25, 680–683.

    Article  PubMed  Google Scholar 

  55. Selleri, C., Sato, T., Anderson, S., Young, N. S., & Maciejewski, J. P. (1995). Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. Journal of Cellular Physiology, 165, 538–546.

    Article  CAS  PubMed  Google Scholar 

  56. Janka, G. E. (2007). Familial and acquired hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 166, 95–109.

    Article  PubMed  Google Scholar 

  57. Freeman, H. R., & Ramanan, A. V. (2011). Review of haemophagocytic lymphohistiocytosis. Archives of Disease in Childhood, 96, 688–693.

    Article  CAS  PubMed  Google Scholar 

  58. Gorelik, M., Fall, N., Altaye, M., Barnes, M. G., Thompson, S. D., Grom, A. A., et al. (2013). Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. The Journal of Rheumatology, 40(7), 1191–1199.

    Article  CAS  PubMed  Google Scholar 

  59. Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003). Heme oxygenase-1: Unleashing the protective properties of heme. Trends in Immunology, 24, 449–455.

    Article  CAS  PubMed  Google Scholar 

  60. Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D., Crooks, D., et al. (2010). Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood, 116(9), 1574–1584.

    Article  CAS  PubMed  Google Scholar 

  61. Schram, A. M., & Berliner, N. (2015). How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood, 125, 2908–2914.

    Article  CAS  PubMed  Google Scholar 

  62. Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., et al. (2014). Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis and Rheumatism, 66(9), 2613–2620.

    Article  Google Scholar 

  63. Hejblum, G., Lambotte, O., Galicier, L., Coppo, P., Marzac, C., Aumontet, C., et al. (2014). A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One, 9(4), e94024.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Ravelli, A., Grom, A. A., Behrens, E. M., & Cron, R. Q. (2012). Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: Diagnosis, genetics, pathophysiology and treatment. Genes and Immunity, 13, 289–298.

    Article  CAS  PubMed  Google Scholar 

  65. Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., et al. (2016). Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against rheumatism/american college of rheumatology/paediatric rheumatology international trials organisation collaborative initiative. Arthritis & Rhematology, 68(3), 566–576.

    Article  Google Scholar 

  66. Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., et al. (2016). Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European League against rheumatism/american college of rheumatology/paediatric rheumatology international trials organisation collaborative initiative. Annals of the Rheumatic Diseases, 75(3), 481–489.

    Article  CAS  PubMed  Google Scholar 

  67. Parodi, A., Davì, S., Pringe, A. B., Pistorio, A., Ruperto, N., Magni-Manzoni, S., et al. (2009). Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients. Arthritis and Rheumatism, 60(11), 3388–3399.

    Article  CAS  PubMed  Google Scholar 

  68. Ravelli, A., Minoia, F., Davì, S., Horne, A. C., Bovis, F., Pistorio, A., et al. (2016). Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open, 2(1), e000161.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Allen, C. E., Yu, X., Kozinetz, C. A., & KL, M. C. (2008). Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 50, 1227–1235.

    Article  Google Scholar 

  70. Schram, A. M., Campigotto, F., Mullally, A., Fogerty, A., Massarotti, E., Neuberg, D., et al. (2015). Marked hyperferritinemia does not predict for HLH in the adult population. Blood, 125(10), 1548.

    Article  CAS  PubMed  Google Scholar 

  71. Kirino, Y., Takeno, M., Iwasaki, M., Ueda, A., Ohno, S., Shiraiet, A., et al. (2005). Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still’s disease: Use in the differential diagnosis of hyperferritinemia. Arthritis Research & Therapy, 7(3), R616–R624.

    Article  CAS  Google Scholar 

  72. Ho, C., Yao, X., Tian, L., Li, F. Y., Podoltsev, N., & Xu, M. L. (2014). Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. American Journal of Clinical Pathology, 141(1), 62–71.

    Article  PubMed  Google Scholar 

  73. Goel, S., Polski, J. M., & Imran, H. (2012 Winter). Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Annals of Clinical and Laboratory Science, 42(1), 21–25.

    PubMed  Google Scholar 

  74. Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., et al. (2007). The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis and Rheumatism, 56, 965–971.

    Article  CAS  PubMed  Google Scholar 

  75. Tsuji, T., Hirano, T., Yamasaki, H., Tsuji, M., & Tsuda, H. (2014). A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Annals of Hematology, 93(5), 821–826.

    Article  CAS  PubMed  Google Scholar 

  76. Schaer, D. J., Schleiffenbaum, B., Kurrer, M., Imhof, A., Bächli, E., Fehr, J., et al. (2005). Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. European Journal of Haematology, 74(1), 6–10.

    Article  CAS  PubMed  Google Scholar 

  77. Tabata, Y., Villanueva, J., Lee, S. M., Zhang, K., Kanegane, H., Miyawaki, T., et al. (2005). Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood, 105, 3066–3071.

    Article  CAS  PubMed  Google Scholar 

  78. Kogawa, K., Lee, S. M., Villanueva, J., Marmer, D., Sumegi, J., Filipovich, A. H., et al. (2002). Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 61–66.

    Article  CAS  PubMed  Google Scholar 

  79. Garcia-Astudillo, L. A., Fontalba, A., Mazorra, F., & Marin, M. J. (2009). Severe course of community-acquired pneumonia in an adult patient who is heterozygous for Q481P in the perforin gene: Are carriers of the mutation free of risk? Journal of Investigational Allergology & Clinical Immunology, 19, 311–316.

    CAS  Google Scholar 

  80. Bryceson, Y. T., Fauriat, C., Nunes, J. M., Wood, S. M., Björkström, N. K., Long, E. O., et al. (2010). Functional analysis of human NK cells by flow cytometry. Methods in Molecular Biology, 612, 335–352.

    Article  CAS  PubMed  Google Scholar 

  81. Marcenaro, S., Gallo, F., Martini, S., Santoro, A., Griffiths, G. M., Aricó, M., et al. (2006). Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): Defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood, 108, 2316–2323.

    Article  CAS  PubMed  Google Scholar 

  82. Schneider, E. M., Lorenz, I., Muller-Rosenberger, M., Steinbach, G., Kron, M., Janka-Schaub, G. E., et al. (2002). Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood, 100, 2891–2898.

    Article  CAS  PubMed  Google Scholar 

  83. Somanchi, S. S., McCulley, K. J., Somanchi, A., Chan, L. L., & Lee, D. A. (2015). A novel method for assessment of natural killer cell cytotoxicity using image cytometry. PLoS One, 10(10), e0141074.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Zhang, M., Bracaglia, C., Prencipe, G., Bemrich-Stolz, C. J., Beukelman, T., Dimmitt, R. A., et al. (2016). A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. Journal of Immunology, 196(6), 2492–2503.

    Article  CAS  Google Scholar 

  85. Janka, G. E., & Schneider, E. M. (2004). Modern management of children with haemophagocytic lymphohistiocytosis. British Journal of Haematology, 124, 4–14.

    Article  PubMed  Google Scholar 

  86. Cetica, V., Pende, D., Griffiths, G. M., & Aricò, M. (2010). Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica, 95, 538–541.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Schulert, G. S., Zhang, M., Fall, N., Husami, A., Kissell, D., Hanosh, A., et al. (2016). Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza. The Journal of Infectious Diseases, 213(7), 1180–1188.

    Article  CAS  PubMed  Google Scholar 

  88. Spessott, W. A., Sanmillan, M. L., McCormick, M. E., Patel, N., Villanueva, J., Zhang, K., et al. (2015). Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. Blood, 125(10), 1566–1577.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Schulert, G. S., Zhang, M., Husami, A., Fall, N., Brunner, H., Zhang, K., et al. (2018). Novel UNC13D intronic variant disrupting a NFκB enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. Arthritis & Rhematology.

    Google Scholar 

  90. Cichocki, F., Schlums, H., Li, H., Stache, V., Holmes, T., Lenvik, T. R., et al. (2014). Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency. The Journal of Experimental Medicine, 211(6), 1079–1091.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Tothova, Z., & Berliner, N. (2015). Hemophagocytic syndrome and critical illness: New insights into diagnosis and management. Journal of Intensive Care Medicine, 30(7), 401–412.

    Article  PubMed  Google Scholar 

  92. Xu, X. J., Tang, Y. M., Song, H., Yang, S. L., Xu, W. Q., Zhao, N., et al. (2012 Jun). Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. The Journal of Pediatrics, 160(6), 984–990.

    Article  CAS  PubMed  Google Scholar 

  93. Shimizu, M., Nakagishi, Y., Inoue, N., Mizuta, M., Ko, G., Saikawa, Y., et al. (2015). Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clinical Immunology, 160(2), 277–281.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Flavia G. Rosado .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosado, F.G., Gopal, P. (2019). Laboratory Features and Pathology of the Cytokine Storm Syndromes. In: Cron, R., Behrens, E. (eds) Cytokine Storm Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-22094-5_4

Download citation

Publish with us

Policies and ethics